Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration

Nature Genetics

Volumn 38, Issue 4, 2006, Pages 458-462

  Gold, Bert ^a   Merriam, Joanna E ^b   Zernant, Jana ^b   Hancox, Lisa S ^c   Taiber, Andrew J ^c   Gehrs, Karen ^c   Cramer, Kevin ^d   Neel, Julia ^d   Bergeron, Julie ^e   Barile, Gaetano R ^b   Smith, R Theodore ^b   Hageman, Gregory S ^c   Dean, Michael ^a   Allikmets, Rando ^b,f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Sapio Sciences   (United States)

^e SAIC FREDERICK INC   (United States)

^f NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3; REGULATOR PROTEIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; GENE LOCATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; AGING; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; COMPLEMENT C2; COMPLEMENT FACTOR B; HAPLOTYPES; HUMANS; IMMUNOHISTOCHEMISTRY; MACULAR DEGENERATION; MOLECULAR SEQUENCE DATA;

EID: 33645419787     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1750     Document Type: Article

References (30)

1. van Leeuwen, R., Klaver, C.C., Vingerling, J.R., Hofman, A. & de Jong, P.T. Epidemiology of age-related maculopathy: a review. Eur. J. Epidemiol. 18, 845-854 (2003).
2. Klein, R., Peto, T., Bird, A. & Vannewkirk, M.R. The epidemiology of age-related macular degeneration. Am. J. Ophthalmol. 137, 486-495 (2004).
3. Hageman, G.S. et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 102, 7227-7232 (2005).
4. Edwards, A.O. et al. Complement factor H polymorphism and age-related macular degeneration. Science 308, 421-424 (2005).
5. Haines, J.L. et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419-421 (2005).
6. Klein, R.J. et al. Complement factor H polymorphism in age-related macular degeneration. Science 308, 385-389 (2005).
7. Zareparsi, S. et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am. J. Hum. Genet. 77, 149-153 (2005).
8. Conley, Y.P. et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum. Mol. Genet. 14, 1991-2002 (2005).
9. Anderson, D.H., Mullins, R.F., Hageman, G.S. & Johnson, L.V. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 134, 411-431 (2002).
10. Hageman, G.S. et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20, 705-732 (2001).
11. Mullins, R.F., Russell, S.R., Anderson, D.H. & Hageman, G.S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 14, 835-846 (2000).
12. Johnson, L.V., Leitner, W.P., Staples, M.K. & Anderson, D.H. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp. Eye Res. 73, 887-896 (2001).
13. Crabb, J.W. et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. USA 99, 14682-14687 (2002).
14. Bok, D. Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc. Natl. Acad. Sci. USA 102, 7053-7054 (2005).
15. Morgan, B.P. & Walport, M.J. Complement deficiency and disease. Immunol. Today 12, 301-306 (1991).
16. Kinoshita, T. Biology of complement: the overture. Immunol. Today 12, 291-295 (1991).
17. Holers, V.M. & Thurman, J.M. The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol. Immunol. 41, 147-152 (2004).
18. Lokki, M.L. & Koskimies, S.A. Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes. Immunogenetics 34, 242-246 (1991).
19. Davis, C.A. & Forristal, J. Partial properdin deficiency. J. Lab. Clin. Med. 96, 633-639 (1980).
20. Raum, D., Glass, D., Carpenter, C.B., Schur, P.H. & Alper, C.A. Mapping of the structural gene for the second component of complement with respect to the human major histocompatibility complex. Am. J. Hum. Genet. 31, 35-41 (1979).
21. Alper, C.A. et al. Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency. J. Clin. Immunol. 23, 297-305 (2003).
22. Stewart, C.A. et al. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res. 14, 1176-1187 (2004).
23. Larsen, C.E. & Alper, C.A. The genetics of HLA-associated disease. Curr. Opin. Immunol. 16, 660-667 (2004).
24. Myers, S., Bottolo, L., Freeman, C., McVean, G. & Donnelly, P.A. Fine-scale map of recombination rates and hotspots across the human genome. Science 310, 321-324 (2005).
25. Goverdhan, S.V. et al. Association of HLA class I and class II polymorphisms with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 46, 1726-1734 (2005).
26. Bird, A.C. et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv. Ophthalmol. 39, 367-374 (1995).
27. Klaver, C.C. et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest. Ophthalmol. Vis. Sci. 42, 2237-2241 (2001).
28. Allikmets, R. et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 277, 1805-1807 (1997).
29. Hayashi, M. et al. Evaluation of the ARMD1 locus on 1q25-31 in patients with age-related maculopathy: genetic variation in laminin genes and in exon 104 of HEMICENTIN-1. Ophthalmic Genet. 25, 111-119 (2004).
30. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289-300 (1995).